JCB logo
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 1 November 2004. doi:10.1083/jcb1673rr2
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 167, Number 3, 396-396
This Article
Right arrow Full Text (PDF, 854K)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wells, W. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wells, W. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Research Roundup

Dormant tumors awaken


What happens during tumor remission? After chemotherapy, tumor cell numbers may be reduced, or surviving cells may enter an altered, dormant state. Evidence for dormancy now comes from Catherine Shachaf, Dean Felsher (Stanford University, Stanford, CA), and colleagues. In their mouse model, liver tumors can be forced into dormancy and then reawakened at will.

As in previous studies, regression was induced by shutting off the oversupply of MYC, in this case using a tetracycline-controlled promoter. Transgenic mice took ~12 weeks to develop the MYC-induced tumors, but within 4 days of MYC inactivation the cells died or differentiated into normal liver cells. Tumors regressed but could later be reactivated by switching MYC back on.

The persistence of dormant tumor cells was demonstrated by transplanting tumor cells containing transgenes for both luciferase and the tetracycline-controlled MYC. Even when MYC was inactivated the luciferase signal persisted in the transplanted cells, which looked like normal liver cells. Turning MYC back on restored tumorigenesis, increasing cell number and thus luciferase activity.

Reversible dormancy has not been seen in previous MYC inactivation studies. Felsher believes that the differences are explained by the properties of the tumors' originating tissues. Lacking MYC, tumor cells from a terminally differentiated tissue such as bone resort to terminal differentiation; those from the apoptotic-prone hematopoietic compartment die; and those from liver (a tissue that is rich in stem cells and can regenerate) differentiate but produce many stem cells. It is those stem cells that may perpetuate the dormant state and that Felsher wants to understand. {rr_end}

Reference:

Shachaf, C.M., et al. 2004. Nature. doi:10.1038/nature03043.



William A. Wells

wellsw{at}rockefeller.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF, 854K)
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wells, W. A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Wells, W. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents